Rugulosin A - Compound Card

Rugulosin A

Select a section from the left sidebar

Rugulosin A

Structure
Zoomed Structure
  • Family: Fungi - Trichocomaceae
  • Kingdom: Fungi
  • Class: Alkaloid
    • Subclass: Cyclic Peptide
Canonical Smiles Cc1cc(O)c2c(c1)C(=O)[C@]13C(=C(O)[C@H]4[C@H]([C@@H]3[C@@H]3[C@@H]([C@H]1C(=C1[C@]43C(=O)c3c(C1=O)c(O)cc(c3)O)O)O)O)C2=O
InChI InChI=1S/C29H20O11/c1-6-2-8-12(10(31)3-6)20(33)16-24(37)19-22(35)14-15-23(36)18(28(14,16)26(8)39)25(38)17-21(34)13-9(27(40)29(15,17)19)4-7(30)5-11(13)32/h2-5,14-15,18-19,22-23,30-32,35-38H,1H3/t14-,15+,18-,19+,22-,23-,28+,29-/m0/s1
InChIKey VQUOYKXFCPDMQL-ITYCUNGFSA-N
Formula C29H20O11
HBA 11
HBD 7
MW 544.47
Rotatable Bonds 0
TPSA 209.89
LogP 1.41
Number Rings 8
Number Aromatic Rings 2
Heavy Atom Count 40
Formal Charge 0
Fraction CSP3 0.31
Exact Mass 544.1
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Talaromyces wortmannii Trichocomaceae Fungi 28567

Showing of synonyms

  • Bara R (2012). Natural Products from Endophytic Fungus Talaromyces wortmannii: Their Structure and mechanism of Actions. PhD Thesis, Institute for Pharmaceutical Biology and Biotechnology, University of Dusseldorf,2012, pp. 1-142.. [View]
Pubchem: 162904213

No compound-protein relationship available.

Structure

SMILES: c1cccc(C2=O)c1C(=O)C(=CC3C4)C2(C4C5C367)C(C5)C=C6C(=O)c8c(C7=O)cccc8

Level: 0

Mol. Weight: 544.47 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.28
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-5.12
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
2.92

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.67
Plasma Protein Binding
84.39
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
9.89
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-3.66
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.78
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
6.66
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-6157.23
Rat (Acute)
3.13
Rat (Chronic Oral)
5.12
Fathead Minnow
15.76
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Toxic
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
522.28
Hydration Free Energy
-2.97
Log(D) at pH=7.4
0.72
Log(P)
4.16
Log S
-4.79
Log(Vapor Pressure)
-8.69
Melting Point
305.25
pKa Acid
7.47
pKa Basic
-0.3

No predicted protein targets found for this compound.

Download SDF